Back
ProShares UltraShort Nasdaq Biotechnology Vs. AXT, Inc. Industry Stock Comparison
Sell
27
BIS
ProShares UltraShort Nasdaq Biotechnology
Last Price:
$8.91
Seasonality Move:
-7.3%
Sell
42
AXTI
AXT, Inc.
Last Price:
$52.95
Seasonality Move:
9.66%
Sell
27
ProShares UltraShort Nasdaq Biotechnology (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotechnology a Buy, Sell or Hold?
-
The current ProShares UltraShort Nasdaq Biotechnology [BIS] share price is $8.77. The Score for BIS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
AXT, Inc. (AXTI)
is a Sell
Is AXT, Inc. a Buy, Sell or Hold?
-
AXTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotechnology's stock price today?
-
The ProShares UltraShort Nasdaq Biotechnology share price today is $8.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight selling pressure.
AXTI Stock Price Chart
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 44.5 | Sell |
| Chaikin Money Flow: | -1577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.71 - 9.55) | Sell |
| Bollinger Bands (100): | (8.68 - 9.8) | Sell |
AXTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.28 | Buy |
| Relative Strength Index (14 RSI): | 53.39 | Buy |
| Chaikin Money Flow: | 15364772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.44 - 59.16) | Buy |
| Bollinger Bands (100): | (10.03 - 41.59) | Buy |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.26 | Sell |
| 20-day SMA: | 9.24 | Sell |
| 50-day SMA: | 8.9 | Sell |
| 200-day SMA: | 11.76 | Sell |
| 8-day EMA: | 9.12 | Sell |
| 20-day EMA: | 9.16 | Sell |
| 50-day EMA: | 9.14 | Sell |
| 200-day EMA: | 11.39 | Sell |
AXTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.08 | Sell |
| 20-day SMA: | 52.05 | Buy |
| 50-day SMA: | 36.82 | Buy |
| 200-day SMA: | 14.71 | Buy |
| 8-day EMA: | 54.71 | Sell |
| 20-day EMA: | 51.49 | Buy |
| 50-day EMA: | 40.68 | Buy |
| 200-day EMA: | 20.19 | Buy |
ProShares UltraShort Nasdaq Biotechnology Earnings Growth & BIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AXT, Inc. Earnings Growth & AXTI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.05 per share, an increase this year of $0.42 per share, and an increase next year of $0.46 per share.
ProShares UltraShort Nasdaq Biotechnology Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AXT, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||